Literature DB >> 2730652

Irreversible inhibition of serine proteases by peptidyl derivatives of alpha-aminoalkylphosphonate diphenyl esters.

J Oleksyszyn1, J C Powers.   

Abstract

Peptidyl alpha-aminoalkylphosphonate diphenyl esters have been synthesized and shown to be effective inhibitors of serine proteases. Extending the peptide chain from a single alpha-aminoalkylphosphonate residue (kobs/[I] = 2.5-260 M-1 s-1) to a tripeptide or tetrapeptide derivative (kobs/[I] = 7,000-17,000 M-1 s-1) resulted in 65-2800 improvement in inhibitory potency and increased specificity. The rate of inactivation of chymotrypsin by MeO-Suc-Ala-Ala-Pro-HNCH(CH2Ph)P(O)(OPh)2 was decreased 5 fold in the presence of the substrate Suc-Val-Pro-Phe-NA (0.119 mM). Phosphonylated serine proteases are extremely stable since the half-life for reactivation was greater than 48 hrs for the inhibited elastases and at least 10 hrs for chymotrypsin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2730652     DOI: 10.1016/0006-291x(89)91572-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Facile Synthesis of Aminomethyl Phosphinate Esters as Serine Protease Inhibitors with Primed Site Interaction.

Authors:  Jan Pascal Kahler; Stijn Lenders; Merel A T van de Plassche; Steven H L Verhelst
Journal:  ACS Med Chem Lett       Date:  2020-08-10       Impact factor: 4.345

2.  The molecular basis of urokinase inhibition: from the nonempirical analysis of intermolecular interactions to the prediction of binding affinity.

Authors:  Renata Grzywa; Edyta Dyguda-Kazimierowicz; Marcin Sieńczyk; Mikołaj Feliks; W Andrzej Sokalski; Józef Oleksyszyn
Journal:  J Mol Model       Date:  2007-03-20       Impact factor: 1.810

3.  New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases.

Authors:  Carla Guarino; Monika Legowska; Christophe Epinette; Christine Kellenberger; Sandrine Dallet-Choisy; Marcin Sieńczyk; Guillaume Gabant; Martine Cadene; Jérôme Zoidakis; Antonia Vlahou; Magdalena Wysocka; Sylvain Marchand-Adam; Dieter E Jenne; Adam Lesner; Francis Gauthier; Brice Korkmaz
Journal:  J Biol Chem       Date:  2014-10-06       Impact factor: 5.157

4.  Development and binding characteristics of phosphonate inhibitors of SplA protease from Staphylococcus aureus.

Authors:  Ewa Burchacka; Michal Zdzalik; Justyna-Stec Niemczyk; Katarzyna Pustelny; Grzegorz Popowicz; Benedykt Wladyka; Adam Dubin; Jan Potempa; Marcin Sienczyk; Grzegorz Dubin; Jozef Oleksyszyn
Journal:  Protein Sci       Date:  2013-12-24       Impact factor: 6.725

5.  Design of a Selective Substrate and Activity Based Probe for Human Neutrophil Serine Protease 4.

Authors:  Paulina Kasperkiewicz; Marcin Poreba; Scott J Snipas; S Jack Lin; Daniel Kirchhofer; Guy S Salvesen; Marcin Drag
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

Review 6.  Emerging challenges in the design of selective substrates, inhibitors and activity-based probes for indistinguishable proteases.

Authors:  Paulina Kasperkiewicz; Marcin Poreba; Katarzyna Groborz; Marcin Drag
Journal:  FEBS J       Date:  2017-01-29       Impact factor: 5.542

Review 7.  Activity-Based Probes to Utilize the Proteolytic Activity of Cathepsin G in Biological Samples.

Authors:  Timo Burster; Fabian Gärtner; Uwe Knippschild; Anuar Zhanapiya
Journal:  Front Chem       Date:  2021-02-25       Impact factor: 5.221

8.  Phosphonate inhibitors of West Nile virus NS2B/NS3 protease.

Authors:  Marcin Skoreński; Aleksandra Milewska; Krzysztof Pyrć; Marcin Sieńczyk; Józef Oleksyszyn
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.